UB Paderborn / Katalog / Suche / in CDI

Pharmacological Analysis Demonstrates Dramatic Alteration of D1 Dopamine Receptor Neuronal Distribution in the Rat Analog of L-DOPA-Induced Dyskinesia

The Journal of neuroscience, 2009-04, Vol.29 (15), p.4829-4835

2009

Volltextzugriff (PDF)

Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates

Brain (London, England : 1878), 2020-05, Vol.143 (5), p.1462-1475

2020

Volltextzugriff (PDF)

Pharmacological Analysis Demonstrates Dramatic Alteration of D 1 Dopamine Receptor Neuronal Distribution in the Rat Analog of l-DOPA-Induced Dyskinesia

The Journal of neuroscience, 2009-04, Vol.29 (15), p.4829-4835

2009

Volltextzugriff (PDF)

Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia

Movement disorders, 2013-07, Vol.28 (8), p.1088-1096

2013

Volltextzugriff (PDF)

Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum

The European journal of neuroscience, 2003-02, Vol.17 (4), p.771-781

2003

Volltextzugriff (PDF)

PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking

The Journal of clinical investigation, 2012-11, Vol.122 (11), p.3977-3989

2012

Volltextzugriff (PDF)

Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonism

Movement disorders, 2018-10, Vol.33 (10), p.1632-1642

2018

Volltextzugriff (PDF)

Evaluation of blood flow as a route for propagation in experimental synucleinopathy

Neurobiology of disease, 2021-03, Vol.150, p.105255-105255, Article 105255

2021

Volltextzugriff (PDF)

Preclinical development of gene therapy for Parkinson's disease

Experimental neurology, 2008-01, Vol.209 (1), p.72-81

2008

Volltextzugriff (PDF)

Immediate-early gene expression in structures outside the basal ganglia is associated to l -DOPA-induced dyskinesia

Neurobiology of disease, 2014-02, Vol.62, p.179-192

2014

Volltextzugriff (PDF)

Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression

Acta neuropathologica communications, 2015-07, Vol.3 (1), p.46, Article 46

2015

Volltextzugriff (PDF)

Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate

PloS one, 2010-10, Vol.5 (10), p.e13306-e13306

2010

Volltextzugriff (PDF)

Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia

Neuroscience research, 2013-12, Vol.77 (4), p.242-246

2013

Volltextzugriff (PDF)

RGS9 2 Negatively Modulates L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia in Experimental Parkinson's Disease

The Journal of neuroscience, 2007-12, Vol.27 (52), p.14338-14348

2007

Volltextzugriff (PDF)

Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain

NPJ Parkinson's Disease, 2023-09, Vol.9 (1), p.135-135, Article 135

2023

Volltextzugriff (PDF)

Comparison of the expression and toxicity of AAV2/9 carrying the human A53T α-synuclein gene in presence or absence of WPRE

Heliyon, 2021-02, Vol.7 (2), p.e06302-e06302, Article e06302

2021

Volltextzugriff (PDF)

Microdialysis in awake macaque monkeys for central nervous system pharmacokinetics

Animal models and experimental medicine, 2018-12, Vol.1 (4), p.314-321

2018

Volltextzugriff (PDF)

Regionally and functionally distinct serotonin3 receptors control in vivo dopamine outflow in the rat nucleus accumbens

Journal of neurochemistry, 2005-07, Vol.94 (1), p.140-149

2005

Volltextzugriff (PDF)

Preclinical development of gene therapy for Parkinson's disease : Gene therapy for parkinson's disease

Experimental neurology, 2008, Vol.209 (1), p.72-81

2008

Volltextzugriff (PDF)

Modeling Parkinson's disease in primates: The MPTP model

Cold Spring Harbor perspectives in medicine, 2012-03, Vol.2 (3), p.a009308-a009308

2012

Volltextzugriff (PDF)

5-HT2A and 5-HT2C/2B Receptor Subtypes Modulate Dopamine Release Induced in Vivo by Amphetamine and Morphine in Both the Rat Nucleus Accumbens and Striatum

Neuropsychopharmacology (New York, N.Y.), 2002-03, Vol.26 (3), p.311-324

2002

Volltextzugriff (PDF)

In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum

Neuropsychopharmacology (New York, N.Y.), 2004-02, Vol.29 (2), p.319-326

2004

Volltextzugriff (PDF)

Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology

Brain (London, England : 1878), 2022-04, Vol.145 (3), p.1001-1017

2022

Volltextzugriff (PDF)

Acute Striato-Cortical Synchronization Induces Focal Motor Seizures in Primates

Cerebral cortex (New York, N.Y. 1991), 2020-11, Vol.30 (12), p.6469-6480

2020

Volltextzugriff (PDF)

Adenosine A2AR/A1R Antagonists Enabling Additional H3R Antagonism for the Treatment of Parkinson’s Disease

Journal of medicinal chemistry, 2021-06, Vol.64 (12), p.8246-8262

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Pharmacological Analysis Demonstrates Dramatic Alteration of D1 Dopamine Receptor Neuronal Distribution in the Rat Analog of L-DOPA-Induced Dyskinesia

Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates

Pharmacological Analysis Demonstrates Dramatic Alteration of D 1 Dopamine Receptor Neuronal Distribution in the Rat Analog of l-DOPA-Induced Dyskinesia

Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia

Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum

PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking

Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonism

Evaluation of blood flow as a route for propagation in experimental synucleinopathy

Preclinical development of gene therapy for Parkinson's disease

Immediate-early gene expression in structures outside the basal ganglia is associated to l -DOPA-induced dyskinesia

Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression

Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate

Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia

RGS9 2 Negatively Modulates L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia in Experimental Parkinson's Disease

Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain

Comparison of the expression and toxicity of AAV2/9 carrying the human A53T α-synuclein gene in presence or absence of WPRE

Microdialysis in awake macaque monkeys for central nervous system pharmacokinetics

Regionally and functionally distinct serotonin3 receptors control in vivo dopamine outflow in the rat nucleus accumbens

Preclinical development of gene therapy for Parkinson's disease : Gene therapy for parkinson's disease

Modeling Parkinson's disease in primates: The MPTP model

5-HT2A and 5-HT2C/2B Receptor Subtypes Modulate Dopamine Release Induced in Vivo by Amphetamine and Morphine in Both the Rat Nucleus Accumbens and Striatum

In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum

Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology

Acute Striato-Cortical Synchronization Induces Focal Motor Seizures in Primates

Adenosine A2AR/A1R Antagonists Enabling Additional H3R Antagonism for the Treatment of Parkinson’s Disease

Suchergebnisse filtern